Cefoxitin: Difference between revisions
(Text replacement - "==Source==" to "==References==") |
(edited dosage forms, strengths, routes of administration) |
||
| Line 1: | Line 1: | ||
==General== | ==General== | ||
*Type: Second generation [[cephalosporin]] | *Type: Second generation [[cephalosporin]] | ||
*Dosage Forms: | *Dosage Forms: powder for injection | ||
*Dosage Strengths: 1g, 2g, 10g | |||
*Route of Administration: IV | |||
*Common Trade Names: | *Common Trade Names: | ||
Revision as of 18:01, 13 October 2017
General
- Type: Second generation cephalosporin
- Dosage Forms: powder for injection
- Dosage Strengths: 1g, 2g, 10g
- Route of Administration: IV
- Common Trade Names:
Adult Dosing
Pediatric Dosing
Special Populations
- Pregnancy:
- Lactation:
- Renal Dosing
- Adult
- Pediatric
- Hepatic Dosing
- Adult
- Pediatric
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
Common
Pharmacology
- Half-life:
- Metabolism:
- Excretion:
- Mechanism of Action:
Antibiotic Sensitivities[1]
Key
- S susceptible/sensitive (usually)
- I intermediate (variably susceptible/resistant)
- R resistant (or not effective clinically)
- S+ synergistic with cell wall antibiotics
- U sensitive for UTI only (non systemic infection)
- X1 no data
- X2 active in vitro, but not used clinically
- X3 active in vitro, but not clinically effective for Group A strep pharyngitis or infections due to E. faecalis
- X4 active in vitro, but not clinically effective for strep pneumonia
See Also
References
- ↑ Sanford Guide to Antimicrobial Therapy 2014